Increased risk of heparin induced thrombocytopenia and thrombosis in patients with essential thrombocythemia carrying the homozygous JAK2 V617F mutation.

J Thromb Thrombolysis

Department of Biomedical and Clinical Sciences Luigi Sacco, Luigi Sacco Hospital, University of Milan, Milan, Italy.

Published: January 2019

Download full-text PDF	Source
http://dx.doi.org/10.1007/s11239-018-1773-4	DOI Listing

Publication Analysis

increased risk

risk heparin

heparin induced

induced thrombocytopenia

thrombocytopenia thrombosis

thrombosis patients

patients essential

essential thrombocythemia

thrombocythemia carrying

carrying homozygous

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!